A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% of all patients and 100% of African American patients. Researchers presented the late-breaking ...

Quantum technologies like quantum computers are built from quantum materials. These types of materials exhibit quantum properties when exposed to the right conditions. Curiously, engineers can also ...

Then I found the aliquot method, and I’ve been nailing loaf after loaf for months without a single dense or gummy crumb. At its core, the aliquot method is a simple workaround for the most ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

Abstract: Data-driven approaches can effectively quantify variations in the operational states of PV strings in solar PV systems. Multi-attribute decision-making methods’ feature weight values relying ...

The goal should be purposeful integration: using records to improve context for education, navigation, and appropriate escalation—without presenting the tool as a substitute for professional judgment.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. TikTok has reached a deal that will allow it to keep operating in the ...

I tend to divide my workday into blocks. Within minutes of waking up — we’re usually up by 5.30 a.m. — I sit down to write at least one Inc. article. Then I spend four to five hours writing a book, ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...